BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 139 found
  Current Search:  glucagon: 139     

HTML
100%
Novo Nordisk Receives Marketing Authorisation For Victoza
Victoza, once-daily human Glucagon-Like Peptide-1 analogue, developed for the treatment of type 2 diabetes Related News Stolen insulin lot numbers are: XZF0036, XZF0037, XZF0038 ...

Liraglutide to treat type 2 diabetes ...

Novo...

Pharmaceutical Business Review:  Jul 4 2009 2:44PM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk A/S -- Regulatory Approval
Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults.

The...

Market Wire via MSN Money:  Jul 3 2009 9:07AM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk A/S -- Regulatory Approval
Novo Nordisk's Victoza(R) (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza(R) for the treatment of type 2 diabetes in adults.
StockHouse USA:  Jul 3 2009 9:04AM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk A/S -- Regulatory Approval
Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults.

The authorisation covers all 27 European Union member states.

Victoza is the brand...

Marketwire via Yahoo!:  Jul 3 2009 8:57AM
Matching: glucagon
Find similar documents
HTML
100%
::: Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe
Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults.

The authorisation covers all 27 European Union member states.

Victoza is the brand...

Biotech Intelligence:  Jul 3 2009 3:13PM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk A/S -- Regulatory Approval
(MARKETWIRE via COMTEX) -- Novo Nordisk's Victoza(R) (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza(R) for the treatment of...
TMC Net:  Jul 3 2009 11:04AM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk A/S -- Regulatory Approval
Novo Nordisk's Victoza(R) (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza(R) for the treatment of type 2 diabetes in adults.
Quote.com Japan:  Jul 3 2009 10:53AM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk A/S -- Regulatory Approval
(MARKETWIRE via COMTEX) -- NVO | Quote | Chart | News | PowerRating -- Novo Nordisk's Victoza(R) (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing...
TradingMarkets:  Jul 3 2009 10:32AM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk A/S -- Regulatory Approval
(MARKETWIRE via COMTEX News Network) -- Novo Nordisk's Victoza(R) (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza(R) for the...
Quote.com Germany:  Jul 3 2009 9:41AM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk A/S -- Regulatory Approval
Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults.

The...

Street Insider:  Jul 3 2009 9:28AM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk's Victoza Gets Marketing Authorisation In Europe -Quick Facts
AM ET RELATED NEWS TOP MARKET NEWS (RTTNews) - Novo Nordisk (NVO: News , NONOF.PK) announced that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults.

The authorisation...

RTTNews.com:  Jul 3 2009 9:27AM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk A/S -- Regulatory Approval
BAGSVAERD, DENMARK, Jul 03 (MARKET WIRE) -- Novo Nordisk's Victoza(R) (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza(R) for...
Reuters:  Jul 3 2009 9:15AM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk A/S -- Regulatory Approval
BAGSVAERD, DENMARK, Jul 03 (MARKET WIRE) -- Novo Nordisk's Victoza(R) (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza(R) for...
Reuters:  Jul 3 2009 9:15AM
Matching: glucagon
Find similar documents
HTML
100%
Regulatory Approval
Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults.

The...

EuroInvestor.co.uk:  Jul 3 2009 9:14AM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk A/S -- Regulatory Approval
BAGSVAERD, DENMARK -- (Marketwire) -- 07/03/09 -- Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for...
PR inside:  Jul 3 2009 9:03AM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk A/S -- Regulatory Approval
Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults.

The...

Stockwatch:  Jul 3 2009 9:01AM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk A/S -- Regulatory Approval
Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults.

The...

Yahoo! Canada:  Jul 3 2009 8:59AM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk A/S -- Regulatory Approval
- Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults.

The...

Market Wire:  Jul 3 2009 8:59AM
Matching: glucagon
Find similar documents
HTML
100%
Novo Nordisk A/S: Novo Nordisk A/S -- Regulatory Approval
SOURCE: Novo Nordisk A/S BAGSVAERD, DENMARK--(Marketwire - July 3, 2009) - Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing...
Market Wire:  Jul 3 2009 8:58AM
Matching: glucagon
Find similar documents
HTML
100%
Lead 6:
Editors' note: Liraglutide, a once-daily glucagon-like peptide-1 receptor agonist, has previously been shown to be effective at reducing glycosylated haemoglobin in patients with type 2 diabetes.

The LEAD-6 trial compares liraglutide...

Lancet:  Jul 3 2009 11:51AM
Matching: glucagon
Find similar documents
HTML
100%
Takeda seeks additional indication of alogliptin for combo therapy with thiazolidinediones
Takeda Pharmaceutical Company Limited (Takeda) announced that it submitted an application for an additional indication of alogliptin (generic name, development code: SYR-322) for combination therapy with thiazolidinediones, and a new drug...
PharmaBiz:  Jun 30 2009 9:33AM
Matching: glucagon
Find similar documents
HTML
100%
Takeda files for an additional indication of Alogliptin
Japanese company, Takeda Pharmaceutical has submitted an application for an additional indication of alogliptin (generic name, development code: SYR-322) for combination therapy with thiazolidinediones, and a new drug application (NDA) of...
Bio Spectrum Asia:  Jun 30 2009 9:31AM
Matching: glucagon
Find similar documents
HTML
100%
Takeda Submitted an Application for an Additional Indication of Alogliptin for Combination Therapy with Thiazo
Takeda Pharmaceutical Company Limited (Takeda) today announced that it submitted an application for an additional indication of alogliptin (generic name, development code: SYR-322) for combination therapy with thiazolidinediones, and a new...
Pharma Live:  Jun 29 2009 2:18PM
Matching: glucagon
Find similar documents
HTML
100%
Diabetes - Research on diabetes described by scientists at University of Ulster
We're a pay-per-view site for premium content.

If you'd like to purchase this article, it's only $3.00.

'Enzyme-resistant glucagon-like peptide-1 (GLP-1) receptor agonists and GIP receptor antagonists have been proposed to have...

NewsRX:  Jun 29 2009 7:20AM
Matching: glucagon
Find similar documents
HTML
100%
ONGLYZA„ (Saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes
(NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that their marketing authorization application for ONGLYZA„ (saxagliptin) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the...
Genetic Engineering News:  Jun 25 2009 6:22PM
Matching: glucagon
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.